Attached files
| file | filename |
|---|---|
| EX-3.A - CERTIFICATE OF INCORPORATION, AS AMENDED TO DATE - AOXING PHARMACEUTICAL COMPANY, INC. | axn10k20100630ex3-a.htm |
| EX-31.1 - RULE 13A-14(A) CERTIFICATION - ZHENJIANG YUE - AOXING PHARMACEUTICAL COMPANY, INC. | axn10k20100630ex31-1.htm |
| EX-31.2 - RULE 13A-14(A) CERTIFICATION - HUI SHAO - AOXING PHARMACEUTICAL COMPANY, INC. | axn10k20100630ex31-2.htm |
| 10-K - AOXING PHARMACEUTICAL COMPANY, INC. FORM 10-K JUNE 30, 2010 - AOXING PHARMACEUTICAL COMPANY, INC. | axn10k20100630.htm |
EXHIBIT 32: Rule 13a-14(b) Certification
The undersigned officer certifies that this report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, and that the information contained in the report fairly presents, in all material respects, the financial condition and results of operations of Aoxing Pharmaceutical Company, Inc.
A signed original of this written statement required by Section 906 has been provided to Aoxing Pharmaceutical Company, Inc. and will be retained by Aoxing Pharmaceutical Company, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
|
October 1, 2010
|
/s/ Zhenjiang Yue
|
|
Zhenjiang Yue, Chief Executive Officer
|
|
|
October 1, 2010
|
/s/ Hui Shao
|
|
Hui Shao, Chief Financial Officer
|